MedPath
FDA Approval

Olopatadine Hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Sandoz Inc
DUNS: 005387188
Effective Date
May 23, 2016
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Olopatadine(665 ug in 100 uL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Sandoz Inc

005387188

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Kyowa Pharma Chemical Co., Ltd.

Sandoz Inc

Sandoz Inc

690852371

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Olopatadine Hydrochloride

Product Details

NDC Product Code
61314-320
Application Number
NDA021861
Marketing Category
NDA authorized generic (C73605)
Route of Administration
NASAL
Effective Date
May 23, 2016
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7Class: IACT
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORMInactive
Code: GR686LBA74Class: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
Code: 2XG66W44KFClass: ACTIMQuantity: 665 ug in 100 uL
© Copyright 2025. All Rights Reserved by MedPath